Pharmacologic Agents for the Treatment of Schizophrenia: Similarities and Differences
Katharine P. Bailey
Abstract
Katharine P. Bailey
Abstract
Although the efficacy of conventional antipsychotic agents is attributed to dopamine receptor antagonism, this blockade induces many adverse effects as welt In addition, conventional antipsychotic agents are relatively ineffective against negative symptoms and have significant rates of nonresponse and relapse. Clozapine and risperidone, "atypical" antipsychotic agents, differ from conventional agents in their receptor-binding profiles and clinical effects. They are effective for acute and treatment-resistant schizophrenia, with different, and perhaps, more tolerable side effect profiles. This article compares the mechanisms of action, efficacy, and adverse effects of the typical and atypical antipsychotic agents.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Although the efficacy of conventional antipsychotic agents is attributed to dopamine receptor antagonism, this blockade induces many adverse effects as welt In addition, conventional antipsychotic agents are relatively ineffective against negative symptoms and have significant rates of nonresponse and relapse. Clozapine and risperidone, "atypical" antipsychotic agents, differ from conventional agents in their receptor-binding profiles and clinical effects. They are effective for acute and treatment-resistant schizophrenia, with different, and perhaps, more tolerable side effect profiles. This article compares the mechanisms of action, efficacy, and adverse effects of the typical and atypical antipsychotic agents.
Key concepts: Clozapine, Risperidone, Schizophrenia (object-oriented programming), Antipsychotic, Atypical antipsychotic, Antipsychotic Agent, Adverse effect, Dopamine receptor D2